Valuation: Ferozsons Laboratories Limited

Market Cap 17.53B 63.1M 54.84M 51.2M 47M 88.63M 6.01B 90.17M 604M 236M 3B 237M 232M 9.89B P/E 2024
15.9x
P/E 2025 21.8x
Enterprise Value 19.46B 70.08M 60.91M 56.86M 52.2M 98.43M 6.68B 100M 670M 263M 3.33B 263M 257M 10.99B EV / Sales 2024
0.93x
EV / Sales 2025 1x
Free-Float
72.55%
Yield 2024
1.2%
Yield 2025 1.03%
1 day+0.75%
1 week+1.59%
Current month+0.75%
1 month-5.80%
3 months+7.36%
6 months-11.08%
Current year+3.25%
1 week 372.73
Extreme 372.73
395
1 month 363
Extreme 363
416.71
Current year 293.01
Extreme 293.01
475
1 year 293.01
Extreme 293.01
475
3 years 133.11
Extreme 133.11
475
5 years 118
Extreme 118
475
10 years 60.33
Extreme 60.3264
745.83
Manager TitleAgeSince
Chief Executive Officer - 1998-12-31
Director of Finance/CFO - 2025-12-18
Director of Finance/CFO - -
Director TitleAgeSince
Chairman - 1991-12-31
Director/Board Member - 1998-12-31
Director/Board Member - 1983-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.75%+1.59%-3.02%+118.02% 60.3M
-2.39%-6.36%+47.10%+149.66% 1,024B
-0.76%-4.34%+52.04%+49.09% 618B
-2.33%-4.60%+25.55%+64.44% 443B
+0.68%-1.14%+38.47%+33.36% 349B
-1.66%-3.13%+32.18%+39.79% 297B
-8.96%-10.77%+3.57%+5.50% 264B
-1.37%-7.41%-2.10%-43.67% 209B
-1.63%+0.69%+27.62%+64.23% 208B
+0.72%+0.48%+15.88%+73.64% 162B
Average -1.31%-2.52%+23.73%+55.41% 357.38B
Weighted average by Cap. -0.98%-3.91%+34.56%+70.87%

Financials

2024 2025
Net sales 15.85B 57.08M 49.61M 46.32M 42.52M 80.18M 5.44B 81.57M 546M 214M 2.71B 214M 210M 8.95B 18.86B 67.89M 59.01M 55.09M 50.57M 95.36M 6.47B 97.02M 650M 254M 3.23B 255M 249M 10.64B
Net income 683M 2.46M 2.14M 2M 1.83M 3.45M 234M 3.51M 23.53M 9.22M 117M 9.24M 9.03M 386M 777M 2.8M 2.43M 2.27M 2.08M 3.93M 266M 4M 26.75M 10.48M 133M 10.5M 10.27M 438M
Net Debt 3.87B 13.94M 12.12M 11.31M 10.38M 19.58M 1.33B 19.92M 133M 52.24M 663M 52.37M 51.21M 2.19B 1.94B 6.98M 6.07M 5.66M 5.2M 9.8M 665M 9.97M 66.78M 26.15M 332M 26.22M 25.64M 1.09B
Logo Ferozsons Laboratories Limited
Ferozsons Laboratories Limited is a Pakistan-based pharmaceutical company. It is engaged in the importing, manufacturing and sale of pharmaceutical products and medical devices. The Company possesses brands in the areas of gastroenterology, hepatology, cardiology, and oncology, with a presence in endocrinology as well as mother and child health the diabetes space. Its segments include Ferozsons, BF Biosciences, and others. The Ferozsons segment is engaged in the import, manufacture, and sale of pharmaceutical products as well as import and sale of medical devices. The BF Biosciences segment is engaged in the import, manufacture, and sale of pharmaceutical products. The others segment is engaged in sale of pharmaceutical and other related products. The Company's subsidiaries include BF Biosciences Limited, which is engaged in the import, manufacturing, and sale of pharmaceutical products and Farmacia, which is engaged in the sale and distribution of medicines and other related products.
Employees
1,556
Date Price Change Volume
26-08-03 PKR 387.97 +0.75% 11,648
26-07-31 PKR 385.10 +1.34% 14,269
26-07-30 PKR 380.00 -0.28% 38,553
26-07-29 PKR 381.07 +1.23% 13,040
26-07-28 PKR 376.43 -1.43% 10,168

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FEROZ Stock